Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

Press releases published on April 20, 2026

Apr. 20, 2026

Palvella Therapeutics to Present QTORIN™ Rapamycin Results from Phase 3 SELVA and Phase 2 TOIVA Studies at the International Society for the Study of Vascular Anomalies World Congress 2026

Indeterminate GlobeNewswire

Apr. 20, 2026

BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting

Indeterminate GlobeNewswire

Apr. 20, 2026

Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region

Indeterminate GlobeNewswire

Apr. 20, 2026

Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors

Indeterminate GlobeNewswire

Apr. 20, 2026

Top Futon Mattress 2026: According to a Sleep Expert

Indeterminate GlobeNewswire

Apr. 20, 2026

Claire’s Place Foundation’s Glow Ride Returns to Hermosa Beach for CF Awareness Month

Indeterminate GlobeNewswire

Apr. 20, 2026

Clearmind Medicine Announced Positive Top-Line Safety Results: CMND-100 Proprietary Psychedelic Treatment Meets Primary Endpoint in AUD Trial

Indeterminate GlobeNewswire

Apr. 20, 2026

Kraig Biocraft Laboratories Advances Record Production and Begins Processing 1.8 Metric Tons of Recombinant Spider Silk Cocoons

Indeterminate GlobeNewswire

Apr. 20, 2026

Pasithea Therapeutics Announces Grant of Rare Pediatric Disease Designation (RPDD) by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1)

Indeterminate GlobeNewswire

Apr. 20, 2026

Invivyd Announces Chairman Marc Elia to Speak at POLITICO Health Care Summit

Indeterminate GlobeNewswire

Apr. 20, 2026

Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026

Indeterminate GlobeNewswire

Apr. 20, 2026

Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer

Indeterminate GlobeNewswire

Apr. 20, 2026

Soleo Health Expands Rare Disease Capabilities With Launch of SoleoRare™, A Specialty Pharmacy Focused on Complex Patient Needs

Indeterminate GlobeNewswire

Apr. 20, 2026

Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026

Indeterminate GlobeNewswire

Apr. 20, 2026

Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates

Indeterminate GlobeNewswire

Apr. 20, 2026

Netramark Comments on U.S. Executive Order to Accelerate Treatments for Serious Mental Illness and Highlights the Need for Regulatory‑Grade Trial Design in Psychedelic Development

Indeterminate GlobeNewswire

Apr. 20, 2026

Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2026 on the Potential of its Cyclin E1 (CCNE1)-directed Molecular Glue Degrader to Treat CCNE1-amplified Solid Tumors

Indeterminate GlobeNewswire

Apr. 20, 2026

NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality

Indeterminate GlobeNewswire

Apr. 20, 2026

Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravascular Imaging

Indeterminate GlobeNewswire

Apr. 20, 2026

Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026

Indeterminate GlobeNewswire